Otros idiomas ProstaLund AB

Acciones

Diferido Nasdaq Stockholm Otros sitios de cotización 09:33:29 03/07/2024			Varia. Cinco días.	Varia. 1 de enero.
0,51 ^SEK	0,00 %		+1,19 %	-68,71 %

31/05	ProstaLund consigue un pedido de un sistema CoreTherm en Austria	MT
16/05	ProstaLund AB (publ) comunica los resultados del primer trimestre finalizado el 31 de marzo de 2024	CI

New agreement - Aarhus in Denmark starts up with CoreTherm® treatments	24/06
ProstaLund Secures Order for CoreTherm System in Austria	31/05
New agreement - MR Prof. Dr Karl Diehl starts up with CoreTherm® treatments in Austria	31/05
ProstaLund AB - Interim report January-March 2024	16/05
ProstaLund AB Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05
ProstaLund hosted unannounced audit by TÜV SÜD	12/04
Two new studies with ProstaLund´s Schelin Catheter® presented at EAU24 in Paris	08/04
ProstaLund AB Presents Two New Studies with Schelin Catheter	08/04
Schelin Catheter® - new study confirms efficiency and ease of use	27/02
Year-end report – ProstaLund AB (publ)	16/02
ProstaLund AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	16/02
New agreement - Esbjerg Hospital starts up with CoreTherm® treatments	12/12
ProstaLund Signs an Agreement on Coretherm®? with the New Customer Sydvestjysk Sygehus	12/12
Interim report - ProstaLund AB (publ)	07/11
ProstaLund AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	07/11
Schelin Catheter® has had its premiere in France.	11/09/23
ProstaLund AB Announces its Schelin Catheter Premiere in France	11/09/23
Schelin Catheter® beneficial together with TURP	05/09/23
ProstaLund signs sales agent agreement for France	31/08/23
Prostalund Signs Sales Agent Agreement for France	31/08/23

No hay resultados para esta búsqueda